Express Scripts (ESRX) Given a $68.00 Price Target by Royal Bank of Canada Analysts
Several other research analysts have also recently issued reports on ESRX. Jefferies Group set a $72.00 target price on shares of Express Scripts and gave the stock a buy rating in a report on Tuesday, August 29th. Robert W. Baird reiterated a hold rating and issued a $56.00 price target on shares of Express Scripts in a research note on Friday, September 1st. ValuEngine lowered shares of Express Scripts from a buy rating to a hold rating in a research note on Friday, September 1st. UBS lowered shares of Express Scripts from a market perform rating to an underperform rating in a research note on Monday, October 9th. Finally, Raymond James Financial reiterated an underperform rating on shares of Express Scripts in a research note on Monday, October 9th. Five research analysts have rated the stock with a sell rating, ten have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of Hold and an average price target of $74.40.
Shares of Express Scripts (ESRX) traded up $2.53 during trading on Friday, reaching $71.55. 8,786,136 shares of the company’s stock traded hands, compared to its average volume of 4,094,484. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61. The stock has a market capitalization of $39,091.06, a PE ratio of 10.09, a PEG ratio of 1.02 and a beta of 0.88. Express Scripts has a twelve month low of $55.80 and a twelve month high of $73.42.
In related news, VP Phyllis S. Anderson sold 643 shares of the business’s stock in a transaction that occurred on Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total transaction of $40,103.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Timothy C. Wentworth bought 8,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 31st. The shares were acquired at an average price of $61.13 per share, with a total value of $489,040.00. Following the completion of the transaction, the chief executive officer now directly owns 98,628 shares of the company’s stock, valued at approximately $6,029,129.64. The disclosure for this purchase can be found here. Insiders own 0.68% of the company’s stock.
A number of hedge funds and other institutional investors have recently made changes to their positions in ESRX. Capital Asset Advisory Services LLC bought a new position in shares of Express Scripts in the second quarter worth approximately $312,000. Factory Mutual Insurance Co. boosted its position in shares of Express Scripts by 2.4% in the second quarter. Factory Mutual Insurance Co. now owns 766,488 shares of the company’s stock worth $48,933,000 after purchasing an additional 18,000 shares during the period. Atria Investments LLC boosted its position in shares of Express Scripts by 53.1% in the second quarter. Atria Investments LLC now owns 9,431 shares of the company’s stock worth $602,000 after purchasing an additional 3,270 shares during the period. Private Trust Co. NA boosted its position in shares of Express Scripts by 13.8% in the second quarter. Private Trust Co. NA now owns 11,351 shares of the company’s stock worth $724,000 after purchasing an additional 1,378 shares during the period. Finally, Confluence Investment Management LLC boosted its position in shares of Express Scripts by 9.5% in the second quarter. Confluence Investment Management LLC now owns 372,228 shares of the company’s stock worth $23,763,000 after purchasing an additional 32,207 shares during the period. Institutional investors own 88.44% of the company’s stock.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.